Protagonist Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 04, 2022 at 04:59 pm EDT
Protagonist Therapeutics, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was USD 41.04 million compared to USD 30.84 million a year ago. Basic loss per share from continuing operations was USD 0.84 compared to USD 0.69 a year ago.
For the six months, net loss was USD 61.97 million compared to USD 54.84 million a year ago. Basic loss per share from continuing operations was USD 1.27 compared to USD 1.23 a year ago.